6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females

Detalhes bibliográficos
Autor(a) principal: de la Rosa, Tomás
Data de Publicação: 2021
Outros Autores: Calvo, Viviam Sanabria, Gonçalves, Valeria Cassia, Scerni, Débora Amado, Scorza, Fúlvio Alexandre
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/212600
Resumo: OBJECTIVES: In addition to the classic motor symptoms of Parkinson’s disease (PD), patients also present with non-motor symptoms, such as autonomic dysfunction, which is present in almost 90% of patients with PD, affecting the quality of life and mortality. Regarding sex differences in prevalence and presentation, there is increasing concern about how sex affects autonomic dysfunction. However, there are no previous data on autonomic cardiac function in females after 6-hydroxydopamine (6-OHDA) striatal injection. METHODS: Wistar female rats were ovariectomized. After 20 days, the animals received bilateral injections of 6-OHDA (total dose per animal: 48 mg) or a vehicle solution in the striatum. Thirty days after 6-OHDA injection, subcutaneous electrodes were implanted for electrocardiogram (ECG) recording. Ten days after electrode implantation, ECG signals were recorded. Analyses of heart rate variability (HRV) parameters were performed, and the 6-OHDA lesion was confirmed by analyzing the number of tyrosine hydroxylase-positive neurons in the substantia nigra pars compacta (SNpc). RESULTS: A high dose of 6-OHDA did not affect HRV of females, independent of ovariectomy. As expected, ovariectomy did not affect HRV or lesions in the SNpc after 6-OHDA injection. CONCLUSIONS: We suggest that females with 6-OHDA present with cardioprotection, independent of ovarian hormones, which could be related to female vagal predominance.
id USP-19_1c397b6bfec5ba571b35a7e24e4d0959
oai_identifier_str oai:revistas.usp.br:article/212600
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling 6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females6-OHDAFemaleOvariectomyHRVOBJECTIVES: In addition to the classic motor symptoms of Parkinson’s disease (PD), patients also present with non-motor symptoms, such as autonomic dysfunction, which is present in almost 90% of patients with PD, affecting the quality of life and mortality. Regarding sex differences in prevalence and presentation, there is increasing concern about how sex affects autonomic dysfunction. However, there are no previous data on autonomic cardiac function in females after 6-hydroxydopamine (6-OHDA) striatal injection. METHODS: Wistar female rats were ovariectomized. After 20 days, the animals received bilateral injections of 6-OHDA (total dose per animal: 48 mg) or a vehicle solution in the striatum. Thirty days after 6-OHDA injection, subcutaneous electrodes were implanted for electrocardiogram (ECG) recording. Ten days after electrode implantation, ECG signals were recorded. Analyses of heart rate variability (HRV) parameters were performed, and the 6-OHDA lesion was confirmed by analyzing the number of tyrosine hydroxylase-positive neurons in the substantia nigra pars compacta (SNpc). RESULTS: A high dose of 6-OHDA did not affect HRV of females, independent of ovariectomy. As expected, ovariectomy did not affect HRV or lesions in the SNpc after 6-OHDA injection. CONCLUSIONS: We suggest that females with 6-OHDA present with cardioprotection, independent of ovarian hormones, which could be related to female vagal predominance.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2021-10-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21260010.6061/clinics/2021/e3175Clinics; Vol. 76 (2021); e3175Clinics; v. 76 (2021); e3175Clinics; Vol. 76 (2021); e31751980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/212600/194603Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessde la Rosa, TomásCalvo, Viviam SanabriaGonçalves, Valeria CassiaScerni, Débora AmadoScorza, Fúlvio Alexandre2023-07-06T13:04:04Zoai:revistas.usp.br:article/212600Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-07-06T13:04:04Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv 6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females
title 6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females
spellingShingle 6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females
de la Rosa, Tomás
6-OHDA
Female
Ovariectomy
HRV
title_short 6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females
title_full 6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females
title_fullStr 6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females
title_full_unstemmed 6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females
title_sort 6-hydroxydopamine and ovariectomy has no effect on heart rate variability parameters of females
author de la Rosa, Tomás
author_facet de la Rosa, Tomás
Calvo, Viviam Sanabria
Gonçalves, Valeria Cassia
Scerni, Débora Amado
Scorza, Fúlvio Alexandre
author_role author
author2 Calvo, Viviam Sanabria
Gonçalves, Valeria Cassia
Scerni, Débora Amado
Scorza, Fúlvio Alexandre
author2_role author
author
author
author
dc.contributor.author.fl_str_mv de la Rosa, Tomás
Calvo, Viviam Sanabria
Gonçalves, Valeria Cassia
Scerni, Débora Amado
Scorza, Fúlvio Alexandre
dc.subject.por.fl_str_mv 6-OHDA
Female
Ovariectomy
HRV
topic 6-OHDA
Female
Ovariectomy
HRV
description OBJECTIVES: In addition to the classic motor symptoms of Parkinson’s disease (PD), patients also present with non-motor symptoms, such as autonomic dysfunction, which is present in almost 90% of patients with PD, affecting the quality of life and mortality. Regarding sex differences in prevalence and presentation, there is increasing concern about how sex affects autonomic dysfunction. However, there are no previous data on autonomic cardiac function in females after 6-hydroxydopamine (6-OHDA) striatal injection. METHODS: Wistar female rats were ovariectomized. After 20 days, the animals received bilateral injections of 6-OHDA (total dose per animal: 48 mg) or a vehicle solution in the striatum. Thirty days after 6-OHDA injection, subcutaneous electrodes were implanted for electrocardiogram (ECG) recording. Ten days after electrode implantation, ECG signals were recorded. Analyses of heart rate variability (HRV) parameters were performed, and the 6-OHDA lesion was confirmed by analyzing the number of tyrosine hydroxylase-positive neurons in the substantia nigra pars compacta (SNpc). RESULTS: A high dose of 6-OHDA did not affect HRV of females, independent of ovariectomy. As expected, ovariectomy did not affect HRV or lesions in the SNpc after 6-OHDA injection. CONCLUSIONS: We suggest that females with 6-OHDA present with cardioprotection, independent of ovarian hormones, which could be related to female vagal predominance.
publishDate 2021
dc.date.none.fl_str_mv 2021-10-11
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/212600
10.6061/clinics/2021/e3175
url https://www.revistas.usp.br/clinics/article/view/212600
identifier_str_mv 10.6061/clinics/2021/e3175
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/212600/194603
dc.rights.driver.fl_str_mv Copyright (c) 2023 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 76 (2021); e3175
Clinics; v. 76 (2021); e3175
Clinics; Vol. 76 (2021); e3175
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222766055555072